Mozambique vs South Africa: Access to anti-retroviral drugs, female
Mozambique
85.0%
in 2024
South Africa
84.0%
in 2024
Mozambique rank
49th
South Africa rank
50th
Access to anti-retroviral drugs, female over time
- Mozambique
- South Africa
How they compare
Mozambique currently reports 85.0% against 84.0% in South Africa, a difference of 1.0%.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was South Africa ahead.
Mozambique ranks 49th and South Africa ranks 50th of 141 countries.
South Africa has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Mozambique | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.4% | 6.1% | 2.7% | South Africa |
| 2010s | 41.4% | 54.6% | 13.2% | South Africa |
| 2020s | 76.6% | 81.8% | 5.2% | South Africa |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Mozambique or South Africa?
- Mozambique, at 85.0% against 84.0% in South Africa as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Mozambique and South Africa?
- 1.0%, with Mozambique ahead.
- How many years of comparable data are there for Mozambique and South Africa?
- 25 years are reported by both, from 2000 to 2024.
- How do Mozambique and South Africa rank globally for access to anti-retroviral drugs, female?
- Mozambique ranks 49th and South Africa ranks 50th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.